arrow
J

James L. Kirkland

Mayo Clinic
H指数:111
被引数:5.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Senolytics dasatinib and quercetin in metabolic dysfunction-associated steatohepatitis: a proof-of-principle randomized, controlled trial

代谢功能障碍相关脂肪性肝炎中的 senolytics 达沙替尼和槲皮素:一项概念验证随机对照试验

2026-10-010
OAAI
Multiomic profiling of responses to clinical and novel bisphosphonates reveals extraskeletal effects on ageing related signatures

对临床和新双膦酸盐反应的多组学分析揭示了其对与年龄相关标志物的骨骼外影响

2026-07-150
OAAI
Author Correction: The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2

作者更正:化疗的疗效受限于表达PD-L2的肿瘤内衰老细胞

2026-05-290
OAAI
Senloytics, dasatinib plus quercetin, reduce kidney inflammation, senescent cell abundance, and injury while restoring geroprotective factors in murine diabetic kidney disease

Senloyatics,达沙替尼加槲皮素,减少肾脏炎症,衰老细胞丰度和损伤,同时恢复小鼠糖尿病肾病的老年保护因子

2026-01-200
OAAI
Pharmacological clearance of senescent cells reduces inflammation, endothelial damage and cardiac fibrosis in HFpEF

清除衰老细胞的药物疗法可减轻炎症、内皮损伤和HFpEF患者的心脏纤维化。

2025-12-011
OAAI
Advancing biological understanding of cellular senescence with computational multiomics

通过计算多组学推进对细胞衰老的生物学理解

2025-09-150
PRE
A pilot study of senolytics to improve cognition and mobility in older adults at risk for Alzheimer's disease

一项关于清除衰老细胞药物以改善阿尔茨海默病风险老年人群认知和活动能力的初步研究

2025-03-011
OAAI